Exparel 266 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FHNQ9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,301
Award facts
- Contract value 100% obligated
- $12,301.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,301.41 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. The contract employs firm fixed-price pricing with an ultimate completion date of December 22, 2025, and carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group Inc. was selected as the awardee based on its established capability to supply specialized pharmaceutical products to Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 billion acquisition vehicle awarded on November 13, 2025, with an ultimate completion date of December 31, 2036. The PPV-G GEN V represents a broader $30.3 billion strategic initiative designed to establish regional prime vendor contractors supplying comprehensive pharmaceutical products—including branded and generic prescription drugs, biologics, and medical consumables—to military healthcare facilities worldwide. The company's extensive product portfolio and demonstrated performance across numerous delivery orders position it as a critical supplier within the federal military medical pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FHNQ9?
SPE2DR26FHNQ9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FHNQ9 worth?
The government has obligated $12,301 on SPE2DR26FHNQ9.
Is contract SPE2DR26FHNQ9 an order under another contract?
Yes. SPE2DR26FHNQ9 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNQ9 competed?
The extent of competition for SPE2DR26FHNQ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award